NEW YORK (GenomeWeb News) – The National Cancer Institute has awarded GeneGo a phase II SBIR grant worth $1 million over two years related to help it discover breast cancer biomarkers, GeneGo said today.
The research program includes a large-scale gene-expression and genotyping study to be conducted at Mayo Clinic. GeneGo will use its MetaCore data-mining program for data analysis.
GeneGo said that in phase I of the grant it performed a network analysis of previously published microarray expression data.